These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 781933)

  • 1. Complement origin determines lytic activity of antibodies to nucleated target cells. Comparison of common complement sources.
    Grant CK
    Transplantation; 1976 Apr; 21(4):323-30. PubMed ID: 781933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appearance of cytolytic antibodies in sheep lymph following immunisation with tumour cells. Identification of antibody subclasses.
    Grant CK; Adams EP; Nass M
    Aust J Exp Biol Med Sci; 1976 Oct; 53(5):381-7. PubMed ID: 820322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the sensitivity of tumor cells and normal lymphocytes toward lysis by alloantibodies and guinea pig or rabbit complement.
    Young-Rodenchuk JM; Gyenes L
    Transplantation; 1975 Jul; 20(1):20-5. PubMed ID: 1166513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic mechanisms detected in vitro following sheep renal allografts.
    Grant CK; Adams EP; Miller HR; Morris B
    Aust J Exp Biol Med Sci; 1975 Dec; 53(6):515-25. PubMed ID: 779749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of mouse complement by different classes of mouse antibody.
    Klaus GG; Pepys MB; Kitajima K; Askonas BA
    Immunology; 1979 Dec; 38(4):687-95. PubMed ID: 521057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of complement activity in adult and preterm sheep serum.
    Ahmed S; Kemp MW; Payne MS; Kallapur SG; Stock SJ; Marsh HC; Jobe AH; Newnham JP; Spiller OB
    Am J Reprod Immunol; 2015 Mar; 73(3):232-41. PubMed ID: 25046333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabbit complement lyses tumor cells without massive C3 deposition.
    Ong GL; Shah PB; Mattes MJ
    Immunol Invest; 1996 May; 25(3):215-29. PubMed ID: 8860693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of high complement levels in Mus hortulanus and BUB mice.
    Ong GL; Baker AE; Mattes MJ
    J Immunol Methods; 1992 Sep; 154(1):37-45. PubMed ID: 1401942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microassay for the determination of hemolytic complement activity in mouse serum.
    Andrews BS; Theofilopoulos AN
    J Immunol Methods; 1978; 22(3-4):273-81. PubMed ID: 355553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic and enhancing properties of early gammaM alloantibodies elicited by first set renal allografts. In vitro and in vivo studies with rat and guinea pig complement on somatic target cells with varying antigen density.
    van Breda Vriesman PJ; Swanen-Sierag L; Vlek LF
    Transplantation; 1975 Nov; 20(5):385-92. PubMed ID: 1108313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of complement in the lysis of mouse sarcoma cells sensitized with H-2 alloantibody.
    Reske-Kunz AB; Scheid MP; Abbott J; Metakis LJ; Polley MJ; Boyse EA
    Transplantation; 1979 Aug; 28(2):149-53. PubMed ID: 483361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.
    Ohanian SH; Schlager SI
    Crit Rev Immunol; 1981 Jan; 1(3):165-209. PubMed ID: 6174273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation.
    Pluschke G; Bordmann G; Daoudaki ME; Lambris JD; Achtman M; Neibert M
    Eur J Immunol; 1989 Jan; 19(1):131-5. PubMed ID: 2646134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-activating properties of some rat alloantibodies.
    Ruszkiewicz M
    Transplantation; 1975 Sep; 20(3):227-36. PubMed ID: 1080612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEPSIN DIGESTION OF RABBIT AND SHEEP ANTIBODIES. THE EFFECT ON COMPLEMENT FIXATION.
    SCHUR PH; BECKER EL
    J Exp Med; 1963 Dec; 118(6):891-904. PubMed ID: 14112269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of graft-versus-host disease using antibody to Thy 1. A role for complement in vivo.
    Hamilton BL; Harris D
    Transplantation; 1985 Jul; 40(1):90-6. PubMed ID: 2861676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement "specificity" and interchangeability: measurement of hemolytic complement levels and use of the complement-fixation test with sera from common domesticated animals.
    Grant CK
    Am J Vet Res; 1977 Oct; 38(10):1611-7. PubMed ID: 337860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysis of sheep red cells in neat autologous serum as a source of antibody and complement.
    Borsos T; Circolo A
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():5-9. PubMed ID: 6587743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.